FDA-Compliant Vaccine Manufacturing and Supply

This contract involves the manufacture and supply of the Japanese Encephalitis Vaccine (JEV) in single-dose prefilled syringes, ensuring full compliance with FDA regulations. The production must meet the specific requirements outlined under MPID Number 5 dated July 23, 2024, indicating adherence to the latest manufacturing and quality standards. The manufacturing is to take place in Philadelphia, with the contract falling under the North American Industry Classification System (NAICS) code 325414, which pertains to pharmaceutical preparation manufacturing. The contract is a subcontract issued by the Department of Defense through the Defense Logistics Agency (DLA) Troop Support, emphasizing its role in supporting military or government health initiatives. The solicitation was posted on May 12, 2026, with responses due by May 29, 2026, defining a short response window for interested parties. The focus on FDA compliance and the use of prefilled syringes indicates a priority on safety, efficacy, and convenience for end-users, most likely for administration within U.S. military or allied healthcare frameworks.